TSS
KRYS icon

Two Sigma Securities’s Krystal Biotech KRYS Stock Holding History

Two Sigma Securities’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,361
Closed -$245K – 1812
2025
Q1 		$245K Buy
+1,361
New +$229K 0.04% 727
2024
Q2 		– Sell
-1,800
Closed -$320K – 3354
2024
Q1 		$320K Buy
+1,800
New +$250K ﹤0.01% 1913
2017
Q4 		– Sell
-13,786
Closed -$137K – 1890
2017
Q3 		$137K Buy
+13,786
New +$139K 0.01% 645

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Two Sigma Securities's KRYS Position: Q2 2025 in Review

Two Sigma Securities sold out of Krystal Biotech (KRYS) in Q2 2025, closing a stake of 1,361 shares — an estimated $245K sold.

Two Sigma Securities first reported a position in KRYS in Q3 2017 and held it in 3 quarters. The position peaked at $320K in Q1 2024. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2025.

  • Two Sigma Securities reported no remaining Krystal Biotech position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,361 Krystal Biotech shares in Q2 2025, an estimated $245K.
  • Two Sigma Securities first reported a position in Krystal Biotech in Q3 2017 and held it in 3 quarters.
  • Two Sigma Securities's Krystal Biotech position peaked at $320K in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.